No venous invasion (n = 8) | Venous invasion (n = 19) | p-value1 | |||
---|---|---|---|---|---|
Sex | 0.33 | ||||
M | 5 | (62.3 %) | 8 | (42.1 %) | |
F | 3 | (37.4 %) | 11 | (57.9 %) | |
Age, mean (STD), yrs | 61.7 | (13.2) | 65.0 | (10.3) | 0.48 |
Preoperative performance status | |||||
ASA | 0.23 | ||||
1/2 | 4 | (50.0 %) | 14 | (73.7 %) | |
3 | 4 | (50.0 %) | 5 | (26.3 %) | |
Diabetes mellitus | 1 | (12.5 %) | 6 | (31.6 %) | 0.41 |
Bile duct stent | 2 | (25.0 %) | 11 | (57.9 %) | 0.23 |
Type of surgery | 0.55 | ||||
ppWhipple/cl-Whipple | 6 | (75.0 %) | 12 | (63.2 %) | |
TP | 2 | (25.0 %) | 7 | (36.8 %) | |
Vein resection technique | 0.19 | ||||
End-to-End anastomosis | 6 | (75.0 %) | 15 | (78.9 %) | |
Wedge- Resection | 2 | (25.0 %) | 1 | (5.3 %) | |
goretex™ graft | 0 | 3 | (15.8 %) | ||
Operative time, mean (STD), min. | 416 | (42) | 379 | (85) | 0.2222 |
c3 | 0.52 | ||||
Grade I/II | 4 | (50.0 %) | 11 | (57.9 %) | |
Grade III/IV | 2 | (25.0 %) | 4 | (21.1 %) | |
Pathological findings | |||||
Tumor grade of differentiation | 0.47 | ||||
G1/G2 | 6 | (75.0 %) | 9 | (47.4 %) | |
G3 | 2 | (25.0 %) | 10 | (52.6 %) | |
T-stage | 0.001 | ||||
T1/T2 | 4 | (50.0 %) | 0 | ||
T3/T4 | 4 | (50.0 %) | 19 | (100.0 %) | |
Nodal status | 0.038 | ||||
N0 | 6 | (75.0 %) | 6 | (31.6 %) | |
N1 | 2 | (25.0 %) | 13 | (68.4 %) | |
Resection margins | 0.36 | ||||
R0 | 4 | (50.0 %) | 6 | (31.6 %) | |
R1 (incl. RX) | 4 | (50.0 %) | 13 | (68.5 %) | |
Localization of tumor | 0.099 | ||||
Pancreatic head | 7 | (87.5 %) | 14 | (73.7 %) | |
Multifocal | 1 | (12.5 %) | 5 | (26.3 %) | |
Pre-operative prediction venous infiltration | |||||
CT/MRT+ | 5 | 11 | Sensitivity: 0.69 | ||
CT/MRT- | 2 | 5 | Specificity: 0.29 |